Zalfermin clinical trials
Also written NNC0194-0499.
- studies test it
- 10
- open now
- 0
- in phase 3
- 0
- first study started
- 2017
How each study uses zalfermin is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Development codes
- NNC0194-0499
- 10
Studies by the year they started
10 studies that test it; most in 2023 (5)
| Year | Studies |
|---|---|
| 2017 | 1 |
| 2018 | 1 |
| 2021 | 1 |
| 2023 | 5 |
| 2024 | 1 |
| 2025 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 10 · Other 0
Often tested with
Tested in the same studies.
Semaglutide (1) · Cagrilintide (1) · NC0194-0499 (1)
Studies
Open first, then newest update. How each study uses zalfermin is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 10
- A Study to See the Effect of NNC0194-0499 Alone or in Combination With Semaglutide on Blood Sugar Control in People Living With Type 1 DiabetesActive, not recruitingPhase 1Novo Nordisk A/SNCT07087795Written as NNC0194-0499
- Effects of NNC0194-0499, Cagrilintide, and Semaglutide Alone or in Combinations on Liver Damage and Alcohol Use in People With Alcohol-related Liver DiseaseCompletedPhase 2Novo Nordisk A/SNCT06409130Written as NNC0194-0499
- A Research Study Looking at How a Single Dose of the Study Medicine NNC0194-0499 Behaves in Participants With Reduced Liver Function Compared to Participants With Normal Liver FunctionCompletedPhase 1Novo Nordisk A/SNCT05917938Written as NNC0194-0499
- A Research Study Looking at How the Compound NNC0194-0499 Works With Birth Control Pills in Women Not Able to Bear Children.CompletedPhase 1Novo Nordisk A/SNCT06188026Written as NNC0194-0499
- A Research Study Looking at How a Single Dose of the Medicine NNC0194-0499 Behaves in Chinese MenCompletedPhase 1Novo Nordisk A/SNCT05742919Written as NNC0194-0499
- A Research Study Comparing Blood Levels of Medicines NNC0194-0499 and Semaglutide Administered as a Combination Formulation Versus Two Separate FormulationsCompletedPhase 1Novo Nordisk A/SNCT05766709Written as NNC0194-0499
- A Research Study Looking Into Blood and Urine Levels of the Medicine NNC0194-0499 in the Body and How Well it is Tolerated in Participants With Reduced Kidney Function and Normal Kidney FunctionCompletedPhase 1Novo Nordisk A/SNCT05727644Written as NNC0194-0499
- A Research Study Looking at How the Medicine NNC0194-0499 Behaves in Japanese and Non-Asian MenCompletedPhase 1Novo Nordisk A/SNCT04722653Written as NNC0194-0499
- A Research Study Looking at a New Study Medicine (NNC0194-0499) for Weight Control in People With Overweight or ObesityCompletedPhase 1Novo Nordisk A/SNCT03479892Written as NNC0194-0499
- First Human Dose Trial Investigating Safety, Tolerability and Pharmacokinetics of NNC0194-0499 in Male Subjects With Overweight or ObesityCompletedPhase 1Novo Nordisk A/SNCT03015207Written as NNC0194-0499
Codes
What other systems call zalfermin · ClinicalTrials.gg INT019038
- UNII (FDA) EHX92ZUE0AZALFERMINOne source FDA
- NCI Thesaurus C203220ZalferminOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| UNII (FDA) | EHX92ZUE0A | ZALFERMIN | One source FDA |
| NCI Thesaurus | C203220 | Zalfermin | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.